Srb Corp Regeneron Pharmaceuticals, Inc. Transaction History

Srb Corp

$1.78 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $77,631 - $85,428	86 Added 13.48%	724 $696,000
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $63,564 - $72,299	82 Added 14.75%	638 $560,000
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $20,773 - $25,331	-30 Reduced 5.12%	556 $457,000
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $70,003 - $83,035	100 Added 20.58%	586 $421,000
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $86,422 - $105,025	-127 Reduced 20.72%	486 $399,000
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $47,294 - $51,348	-67 Reduced 9.85%	613 $442,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $897,689 - $1.13 Million	-1,564 Reduced 69.7%	680 $468,000
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $44,964 - $60,584	82 Added 3.79%	2,244 $1.33 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $208,696 - $257,652	-384 Reduced 15.08%	2,162 $1.37 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $1.46 Million - $1.73 Million	2,546 New	2,546 $1.54 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $1.55 Million - $1.83 Million	-3,280 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $797,859 - $979,085	1,786 Added 119.54%	3,280 $1.55 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $266,891 - $339,252	558 Added 59.62%	1,494 $721,000
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $509,886 - $616,084	936 New	936 $524,000
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $662,528 - $864,784	-1,343 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$336.18 - $494.43 $50,427 - $74,164	-150 Reduced 10.05%	1,343 $656,000
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $408,275 - $475,356	1,493 New	1,493 $414,000
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $504,226 - $698,142	-1,683 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $565,185 - $678,316	1,683 New	1,683 $629,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Srb Corp, based on Form 13F filings with the SEC.

News

Stay updated on Srb Corp with notifications on news.

Account